Th(is)²Modeling
The computed 12-month bankruptcy probability of Th(is)²Modeling is 0.2% (very low). The 2024 annual accounts show equity of €148k and a net result of €145k. Its solvency ranks better than 59% of 6543 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €148k |
| Net result | €145k |
| Staff (FTE) | 2 |
| Better than sector | 59% |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 73.9% | 66.7% | |
| Net result | €145k | €46k | |
| Equity | €148k | €79k | |
| Gross operating margin | €327k | €79k | |
| Staff costs | €140k | €21k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €145k |
| Cash flow | - |
| Staff costs | €140k |
| Income taxes | €42k |
| Dividends | - |
| Total assets | €200k |
| Equity | €148k |
| Debt | €52k |
| of which ≤ 1y | €52k |
| of which > 1y | - |
| Working capital | €148k |
| Employees (FTE) | 2.0 |
| 2024 | |
|---|---|
| Current ratio | 3.84 |
| Quick ratio | 3.84 |
| Working capital ratio | 73.9% |
| Solvency | 73.9% |
| Debt / equity | 0.35 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 72.4% |
| ROE | 98.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €200k |
| Current assets | 29/58 | €200k |
| Amounts receivable within one year | 40/41 | €119k |
| Cash & bank | 54/58 | €78k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €200k |
| Equity | 10/15 | €148k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €145k |
| Amounts payable | 17/49 | €52k |
| Amounts payable within one year | 42/48 | €52k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €327k |
| Operating result | 9901 | €187k |
| Financial income | 75 | €2 |
| Financial charges | 65 | €140 |
| Result before taxes | 9903 | €187k |
| Income taxes | 67/77 | €42k |
| Net result for the period | 9904 | €145k |
| Result to be appropriated | 9905 | €145k |
| NACE primary | Human health(86995) |
| Legal form | Private limited company(610) |
| Incorporation | 07-08-2023 |
| Status | Active |
| Postal code | 1730 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23002H0365/00P000 | Flanders | 1,408 m² | 1 · 171 m² | 7.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Th(is)²Modeling |